Increased iron stores correlate with worse disease outcomes in a mouse model of schistosomiasis infection

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  McDonald, Cameron J ^a   Jones, Malcolm K ^a,b   Wallace, Daniel F ^a   Summerville, Lesa ^a   Nawaratna, Sujeevi ^a,b   Subramaniam, V Nathan ^a,b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPCIDIN; TRANSFERRIN RECEPTOR 2; IRON; TRANSFERRIN RECEPTOR; TRFR2 PROTEIN, MOUSE;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DISEASE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EGG PRODUCTION; FEMALE; FIBROSIS; GRANULOMA; HEMOCHROMATOSIS; INFLAMMATION; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; WESTERN BLOTTING; WILD TYPE; ANIMAL; C57BL MOUSE; GENE EXPRESSION REGULATION; HOMEOSTASIS; LIVER; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHISTOSOMIASIS HAEMATOBIA; TREATMENT OUTCOME;

ANIMALIA; MUS; SCHISTOSOMA; SCHISTOSOMA JAPONICUM;

ANIMALS; BLOTTING, WESTERN; FEMALE; GENE EXPRESSION REGULATION; HOMEOSTASIS; INFLAMMATION; IRON; LIVER; MICE; MICE, INBRED C57BL; RECEPTORS, TRANSFERRIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS JAPONICA; TREATMENT OUTCOME;

EID: 77949707165     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009594     Document Type: Article

References (34)

1. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411-425.
2. Steinmann P, Zhou XN, Li YL, Li HJ, Chen SR, et al. (2007) Helminth infections and risk factor analysis among residents in Eryuan county, Yunnan province, China. Acta Trop 104: 38-51.
3. Friedman JF, Kanzaria HK, McGarvey ST (2005) Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends Parasitol 21: 386-392.
4. King CH, Dangerfield-Cha M (2008) The unacknowledged impact of chronic schistosomiasis. Chronic Illn 4: 65-79.
5. Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, et al. (2002) Schistosomiasis. N Engl J Med 346: 1212-1220.
6. Burke ML, Jones MK, Gobert GN, Li YS, Ellis MK, et al. (2009) Immunopathogenesis of human schistosomiasis. Parasite Immunol 31: 163-176.
7. Pearce EJ (2005) Priming of the immune response by schistosome eggs. Parasite Immunol 27: 265-270.
8. Bartley PB, Ramm GA, Jones MK, Ruddell RG, Li Y, et al. (2006) A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis. Int J Parasitol 36: 993-1001.
9. Chang D, Ramalho LN, Ramalho FS, Martinelli AL, Zucoloto S (2006) Hepatic stellate cells in human schistosomiasis mansoni: a comparative immunohisto-chemical study with liver cirrhosis. Acta Trop 97: 318-323.
10. Stavitsky AB (2004) Regulation of granulomatous inflammation in experimental models of schistosomiasis. Infect Immun 72: 1-12.
11. Ezeamama AE, Friedman JF, Olveda RM, Acosta LP, Kurtis JD, et al. (2005) Functional significance of low-intensity polyparasite helminth infections in anemia. J Infect Dis 192: 2160-2170.
12. Leenstra T, Acosta LP, Langdon GC, Manalo DL, Su L, et al. (2006) Schistosomiasis japonica, anemia, and iron status in children, adolescents, and young adults in Leyte, Philippines 1. Am J Clin Nutr 83: 371-379.
13. Leenstra T, Coutinho HM, Acosta LP, Langdon GC, Su L, et al. (2006) Schistosoma japonicum reinfection after praziquantel treatment causes anemia associated with inflammation. Infect Immun 74: 6398-6407.
14. Kanzaria HK, Acosta LP, Langdon GC, Manalo DL, Olveda RM, et al. (2005) Schistosoma japonicum and occult blood loss in endemic villages in Leyte, the Philippines. Am J Trop Med Hyg 72: 115-118.
15. Coutinho HM, Acosta LP, Wu HW, McGarvey ST, Su L, et al. (2007) Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection. J Infect Dis 195: 288-295.
16. Coutinho HM, McGarvey ST, Acosta LP, Manalo DL, Langdon GC, et al. (2005) Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibrosis, in Leyte, Philippines. J Infect Dis 192: 528-536.
17. Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D (2005) Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106: 1864-1866.
18. Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, et al. (2009) Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 113: 5277-5286.
19. Nemeth E, Ganz T (2006) Regulation of iron metabolism by hepcidin. Annu Rev Nutr 26: 323-342.
20. Ganz T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102: 783-788.
21. de Mast Q, van Dongen-Lases EC, Swinkels DW, Nieman AE, Roestenberg M, et al. (2009) Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection. Br J Haematol 145: 657-664.
22. Wallace DF, Subramaniam VN (2007) Non-HFE haemochromatosis. World J Gastroenterol 13: 4690-4698.
23. Wallace DF, Summerville L, Lusby PE, Subramaniam VN (2005) First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin. Gut 54: 980-986.
24. Drake SF, Morgan EH, Herbison CE, Delima R, Graham RM, et al. (2007) Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3. Am J Physiol Gastrointest Liver Physiol 292: G323-328.
25. Clemens LE, Basch PF (1989) Schistosoma mansoni: effect of transferrin and growth factors on development of schistosomula in vitro. J Parasitol 75: 417-421.
26. Jones MK, McManus DP, Sivadorai P, Glanfield A, Moertel L, et al. (2007) Tracking the fate of iron in early development of human blood flukes. Int J Biochem Cell Biol 39: 1646-1658.
27. Fleck A, Myers M (1985) Diagnostic and prognostic significance of the acute phase proteins. In: Gordon A, Koj A, eds. The acute phase response to injury and infection. Amsterdam: Elsevier Science Publishers. pp 249-271.
28. Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352: 1011-1023.
29. Friis H, Mwaniki D, Omondi B, Muniu E, Thiong'o F, et al. (2003) Effects on haemoglobin of multi-micronutrient supplementation and multi-helminth chemotherapy: a randomized, controlled trial in Kenyan school children. Eur J Clin Nutr 57: 573-579.
30. WHO (2007) Assessing the Iron Status of Populations: Second edition including literature review. Geneva: WHO.
31. Cherian S, Forbes DA, Cook AG, Sanfilippo FM, Kemna EH, et al. (2008) An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross-sectional study. PLoS One 3: e4030.
32. Ramm GA, Crawford DH, Powell LW, Walker NI, Fletcher LM, et al. (1997) Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol 26: 584-592.
33. Denic S, Agarwal MM (2007) Nutritional iron deficiency: an evolutionary perspective. Nutrition 23: 603-614.
34. ILAR (1996) Guide for the Care and Use of Laboratory Animals. In: NIH, ed. Washington: National Academy of Sciences.